- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 515/02 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 515/02
Total number of patents in this class: 75
10-year publication summary
|
3
|
2
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biosplice Therapeutics, Inc. | 160 |
6 |
| Bristol-myers Squibb Company | 4761 |
4 |
| Astex Therapeutics Limited | 207 |
3 |
| Crestone, Inc. | 15 |
3 |
| Janssen Sciences Ireland UC | 153 |
3 |
| Merck Sharp & Dohme LLC | 3734 |
3 |
| L'OREAL, Société Anonyme | 16572 |
2 |
| Askat Inc. | 49 |
2 |
| Cancer Research Technology Limited | 516 |
2 |
| Carna Biosciences, Inc. | 68 |
2 |
| Daiichi Sankyo Company, Limited | 1894 |
2 |
| Incyte Holdings Corporation | 619 |
2 |
| Jiangsu Vcare PharmaTech Co., Ltd. | 39 |
2 |
| Merial, Inc. | 208 |
2 |
| Glaxo Group Limited | 4353 |
1 |
| Novartis AG | 10172 |
1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 58 |
1 |
| Allergan, Inc. | 2146 |
1 |
| Bayer Cropscience AG | 1821 |
1 |
| Amgen Inc. | 4486 |
1 |
| Other owners | 31 |